From: KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
Gender
KRASwild-type n (%)
KRASmutant n (%)
Total n (%)
5,174 (66.4)
2,623 (33.6)
7,797 (100)
Female
2,440 (65.2)
1,305 (34.8)
3,745 (100)
Male
2,734 (67.5)
1,318 (32.5)
4,052 (100)